{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:09:10Z","timestamp":1764076150513,"version":"3.45.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Traditional Chinese Medicine Research Project of Zhejiang Province","award":["2025ZL524","2025ZL524"],"award-info":[{"award-number":["2025ZL524","2025ZL524"]}]},{"DOI":"10.13039\/501100005315","name":"Natural Science Foundation of Ningbo Municipality","doi-asserted-by":"publisher","award":["2023J221","2023J221"],"award-info":[{"award-number":["2023J221","2023J221"]}],"id":[{"id":"10.13039\/501100005315","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017531","name":"Medical and Health Research Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2024KY1480"],"award-info":[{"award-number":["2024KY1480"]}],"id":[{"id":"10.13039\/501100017531","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ningbo Public Welfare Science and Technology Project","award":["2024S159"],"award-info":[{"award-number":["2024S159"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-04010-z","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:06:49Z","timestamp":1764072409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Decoding the cholesterol\u2013apoptosis axis in HCC: a machine learning-based multi-omics integration and single-cell transcriptomic analysis"],"prefix":"10.1007","volume":"16","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"3","key":"4010_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"4010_CR2","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s00292-020-00801-z","volume":"41","author":"T Longerich","year":"2020","unstructured":"Longerich T. Hepatozellul\u00e4res Karzinom [Hepatocellular carcinoma]. Pathologe. 2020;41(5):478\u201387. German.","journal-title":"Pathologe"},{"key":"4010_CR3","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","volume":"2","author":"JM Llovet","year":"2016","unstructured":"Llovet JM, Zucman-Rossi J, Pikarsky E, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"4010_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/CEJ.0000000000000428","volume":"27","author":"A Baecker","year":"2018","unstructured":"Baecker A, Liu X, La Vecchia C, et al. Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors. Eur J Cancer Prev. 2018;27(3):205\u201312.","journal-title":"Eur J Cancer Prev"},{"issue":"4","key":"4010_CR5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.21037\/hbsn-20-480","volume":"9","author":"DY Xie","year":"2020","unstructured":"Xie DY, Ren ZG, Zhou J, et al. 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights. Hepatobiliary Surg Nutr. 2020;9(4):452\u201363.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"10126","key":"4010_CR6","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","volume":"391","author":"M Kudo","year":"2018","unstructured":"Kudo M, Finn RS, Qin S, et al. Lenvatinib versus Sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet. 2018;391(10126):1163\u201373.","journal-title":"Lancet"},{"issue":"10064","key":"4010_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","volume":"389","author":"J Bruix","year":"2017","unstructured":"Bruix J, Qin S, Merle P, et al. Regorafenib for patients with hepatocellular carcinoma who progressed on Sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;389(10064):56\u201366.","journal-title":"Lancet"},{"issue":"7","key":"4010_CR8","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S1470-2045(18)30351-6","volume":"19","author":"AX Zhu","year":"2018","unstructured":"Zhu AX, Finn RS, Edeline J, et al. Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with Sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial. Lancet Oncol. 2018;19(7):940\u201352.","journal-title":"Lancet Oncol"},{"issue":"3","key":"4010_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000488035","volume":"7","author":"J Zhou","year":"2018","unstructured":"Zhou J, Sun HC, Wang Z, et al. Guidelines for diagnosis and treatment of primary liver cancer in China (2017 Edition). Liver Cancer. 2018;7(3):235\u201360.","journal-title":"Liver Cancer"},{"issue":"1","key":"4010_CR10","doi-asserted-by":"publisher","first-page":"13639","DOI":"10.1038\/s41598-022-17954-x","volume":"12","author":"L Dai","year":"2022","unstructured":"Dai L, Mugaanyi J, Cai X, et al. Comprehensive bioinformatic analysis of MMP1 in hepatocellular carcinoma and establishment of relevant prognostic model. Sci Rep. 2022;12(1):13639.","journal-title":"Sci Rep"},{"issue":"1","key":"4010_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cld.2022.08.004","volume":"27","author":"P Ganesan","year":"2023","unstructured":"Ganesan P, Kulik LM. Hepatocellular carcinoma: new developments. Clin Liver Dis. 2023;27(1):85\u2013102.","journal-title":"Clin Liver Dis"},{"issue":"1","key":"4010_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"4010_CR13","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","volume":"6","author":"H Zeng","year":"2018","unstructured":"Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018;6(5):e555\u201367.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"4010_CR14","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1038\/s41467-018-06931-6","volume":"9","author":"JQ Liang","year":"2018","unstructured":"Liang JQ, Teoh N, Xu L, et al. Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling. Nat Commun. 2018;9(1):4490.","journal-title":"Nat Commun"},{"key":"4010_CR15","doi-asserted-by":"publisher","first-page":"118796","DOI":"10.1016\/j.lfs.2020.118796","volume":"265","author":"W Yang","year":"2021","unstructured":"Yang W, Liu J, Hou L, et al. Shikonin differentially regulates glucose metabolism via PKM2 and HIF1\u03b1 to overcome apoptosis in a refractory HCC cell line. Life Sci. 2021;265:118796.","journal-title":"Life Sci"},{"issue":"5","key":"4010_CR16","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3892\/ol.2022.13530","volume":"24","author":"M Gryziak","year":"2022","unstructured":"Gryziak M, Wozniak K, Kraj L, et al. The immune landscape of hepatocellular carcinoma-where we are? Oncol Lett. 2022;24(5):410.","journal-title":"Oncol Lett"},{"issue":"4","key":"4010_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495\u2013516.","journal-title":"Toxicol Pathol"},{"issue":"2","key":"4010_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","volume":"2","author":"B Huang","year":"2020","unstructured":"Huang B, Song BL, Xu C. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. Nat Metab. 2020;2(2):132\u201341.","journal-title":"Nat Metab"},{"issue":"8","key":"4010_CR19","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"4010_CR20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138.","journal-title":"Nat Biotechnol"},{"issue":"21","key":"4010_CR21","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.1158\/1078-0432.CCR-06-2236","volume":"13","author":"SM Wang","year":"2007","unstructured":"Wang SM, Ooi LL, Hui KM. Identification and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma. Clin Cancer Res. 2007;13(21):6275\u201383.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4010_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/1878-0261.12153","volume":"12","author":"OV Grinchuk","year":"2018","unstructured":"Grinchuk OV, Yenamandra SP, Iyer R, et al. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma. Mol Oncol. 2018;12(1):89\u2013113.","journal-title":"Mol Oncol"},{"issue":"Database issue","key":"4010_CR23","first-page":"D991","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets\u2013update. Nucleic Acids Res. 2013;41(Database issue):D991\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"4010_CR24","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","volume":"23","author":"S Davis","year":"2007","unstructured":"Davis S, Meltzer PS. GEOquery: a Bridge between the gene expression omnibus (GEO) and bioconductor. Bioinformatics. 2007;23(14):1846\u20137.","journal-title":"Bioinformatics"},{"issue":"7","key":"4010_CR25","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"key":"4010_CR26","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1002\/cpbi.5","volume":"54","author":"G Stelzer","year":"2016","unstructured":"Stelzer G, Rosen N, Plaschkes I, et al. The genecards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinf. 2016;54:1301\u201313033.","journal-title":"Curr Protoc Bioinf"},{"key":"4010_CR27","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1016\/j.csbj.2022.07.030","volume":"20","author":"L Tang","year":"2022","unstructured":"Tang L, Wei R, Chen R, et al. Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma. Comput Struct Biotechnol J. 2022;20:4402\u201314.","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"4010_CR28","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1038\/s41467-022-32283-3","volume":"13","author":"Y Lu","year":"2022","unstructured":"Lu Y, Yang A, Quan C, et al. A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma. Nat Commun. 2022;13(1):4594.","journal-title":"Nat Commun"},{"issue":"13","key":"4010_CR29","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(13):3573\u2013e358729.","journal-title":"Cell"},{"issue":"12","key":"4010_CR30","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"18","key":"4010_CR31","doi-asserted-by":"publisher","first-page":"427","DOI":"10.21037\/atm.2019.08.113","volume":"7","author":"C Zhang","year":"2019","unstructured":"Zhang C, Zheng Y, Li X, et al. Genome-wide mutation profiling and related risk signature for prognosis of papillary renal cell carcinoma. Ann Transl Med. 2019;7(18):427.","journal-title":"Ann Transl Med"},{"issue":"1","key":"4010_CR32","doi-asserted-by":"publisher","first-page":"11944","DOI":"10.1038\/s41598-022-16155-w","volume":"12","author":"L Dai","year":"2022","unstructured":"Dai L, Mugaanyi J, Cai X, et al. Pancreatic adenocarcinoma associated immune-gene signature as a Novo risk factor for clinical prognosis prediction in hepatocellular carcinoma. Sci Rep. 2022;12(1):11944.","journal-title":"Sci Rep"},{"issue":"1","key":"4010_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13148-019-0730-1","volume":"11","author":"S Engebretsen","year":"2019","unstructured":"Engebretsen S, Bohlin J. Statistical predictions with Glmnet. Clin Epigenetics. 2019;11(1):123.","journal-title":"Clin Epigenetics"},{"issue":"3","key":"4010_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.otohns.2010.05.007","volume":"143","author":"JT Rich","year":"2010","unstructured":"Rich JT, Neely JG, Paniello RC, et al. A practical guide to Understanding Kaplan-Meier curves. Otolaryngol Head Neck Surg. 2010;143(3):331\u20136.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"4010_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3348\/kjr.2004.5.1.11","volume":"5","author":"SH Park","year":"2004","unstructured":"Park SH, Goo JM, Jo CH. Receiver operating characteristic (ROC) curve: practical review for radiologists. Korean J Radiol. 2004;5(1):11\u20138.","journal-title":"Korean J Radiol"},{"issue":"6","key":"4010_CR36","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","volume":"74","author":"B Van Calster","year":"2018","unstructured":"Van Calster B, Wynants L, Verbeek JFM, et al. Reporting and interpreting decision curve analysis: A guide for investigators. Eur Urol. 2018;74(6):796\u2013804.","journal-title":"Eur Urol"},{"key":"4010_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"4010_CR38","doi-asserted-by":"publisher","first-page":"e14343","DOI":"10.1111\/cns.14343","volume":"30","author":"Z Chen","year":"2024","unstructured":"Chen Z, Hao Q, Sun R, et al. Predictive value of the geriatric nutrition risk index for postoperative delirium in elderly patients undergoing cardiac surgery. CNS Neurosci Ther. 2024;30(2):e14343.","journal-title":"CNS Neurosci Ther"},{"issue":"D1","key":"4010_CR39","doi-asserted-by":"publisher","first-page":"D419","DOI":"10.1093\/nar\/gky1038","volume":"47","author":"H Mi","year":"2019","unstructured":"Mi H, Muruganujan A, Ebert D, et al. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47(D1):D419\u201326.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"4010_CR40","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, et al. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"1","key":"4010_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"4010_CR42","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41596-018-0103-9","volume":"14","author":"J Reimand","year":"2019","unstructured":"Reimand J, Isserlin R, Voisin V, et al. Pathway enrichment analysis and visualization of omics data using g: Profiler, GSEA, cytoscape and enrichmentmap. Nat Protoc. 2019;14(2):482\u2013517.","journal-title":"Nat Protoc"},{"issue":"12","key":"4010_CR43","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, Subramanian A, Pinchback R, et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27(12):1739\u201340.","journal-title":"Bioinformatics"},{"issue":"D1","key":"4010_CR44","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"4010_CR45","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"issue":"D1","key":"4010_CR46","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X. MiRDB: an online database for prediction of functional MicroRNA targets. Nucleic Acids Res. 2020;48(D1):D127\u201331.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"4010_CR47","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"W1","key":"4010_CR48","doi-asserted-by":"publisher","first-page":"W534","DOI":"10.1093\/nar\/gkaf388","volume":"53","author":"H Cui","year":"2025","unstructured":"Cui H, Zhao G, Lu Y, et al. TIMER3: an enhanced resource for tumor immune analysis. Nucleic Acids Res. 2025;53(W1):W534\u201341.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4010_CR49","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1038\/s41467-023-41374-8","volume":"14","author":"F Chen","year":"2023","unstructured":"Chen F, Zhang Y, Chandrashekar DS, et al. Global impact of somatic structural variation on the cancer proteome. Nat Commun. 2023;14(1):5637.","journal-title":"Nat Commun"},{"issue":"1","key":"4010_CR50","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1038\/s41467-023-41132-w","volume":"14","author":"H Jin","year":"2023","unstructured":"Jin H, Zhang C, Zwahlen M, et al. Systematic transcriptional analysis of human cell lines for gene expression landscape and tumor representation. Nat Commun. 2023;14(1):5417.","journal-title":"Nat Commun"},{"issue":"38","key":"4010_CR51","doi-asserted-by":"publisher","first-page":"5759","DOI":"10.3748\/wjg.v26.i38.5759","volume":"26","author":"S D\u2019souza","year":"2020","unstructured":"D\u2019souza S, Lau KC, Coffin CS, et al. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World J Gastroenterol. 2020;26(38):5759\u201383.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4010_CR52","doi-asserted-by":"publisher","first-page":"112169","DOI":"10.1016\/j.yexcr.2020.112169","volume":"395","author":"H Chang","year":"2020","unstructured":"Chang H, Wang Y, Wu Y, et al. Cardiac apoptosis caused by elevated cholesterol level in experimental autoimmune myocarditis. Exp Cell Res. 2020;395(1):112169.","journal-title":"Exp Cell Res"},{"issue":"1","key":"4010_CR53","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41419-025-07625-w","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Lan T, Zhou C, et al. LRP8-dependent cholesterol metabolism modulates mTORC1 signaling and apoptotic pathways in multiple myeloma. Cell Death Dis. 2025;16(1):263.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4010_CR54","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12885-022-09209-9","volume":"22","author":"J Kong","year":"2022","unstructured":"Kong J, Yu G, Si W, et al. Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma. BMC Cancer. 2022;22(1):142.","journal-title":"BMC Cancer"},{"issue":"3","key":"4010_CR55","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3892\/mmr.2021.12289","volume":"24","author":"K Zhan","year":"2021","unstructured":"Zhan K, Bai Y, Liao S, et al. Identification and validation of EPHX2 as a prognostic biomarker in hepatocellular carcinoma. Mol Med Rep. 2021;24(3):650.","journal-title":"Mol Med Rep"},{"key":"4010_CR56","doi-asserted-by":"publisher","first-page":"155844","DOI":"10.1016\/j.phymed.2024.155844","volume":"132","author":"Y Gao","year":"2024","unstructured":"Gao Y, Zhao P, Wang C, et al. Buqi Huoxue Tongnao prescription protects against chronic cerebral hypoperfusion via regulating PI3K\/AKT and LXR\u03b1\/CYP7A1 signaling pathways. Phytomedicine. 2024;132:155844.","journal-title":"Phytomedicine"},{"key":"4010_CR57","doi-asserted-by":"publisher","first-page":"870721","DOI":"10.3389\/fonc.2022.870721","volume":"12","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Li X, Guan A, et al. EPHX2 inhibits colon cancer progression by promoting fatty acid degradation. Front Oncol. 2022;12:870721.","journal-title":"Front Oncol"},{"issue":"3","key":"4010_CR58","first-page":"e70188","volume":"8","author":"W Hu","year":"2025","unstructured":"Hu W, Ding X, Wu X, et al. A comprehensive analysis of epoxide hydrolase 2 (EPHX2) in Pan-Cancer. Cancer Rep (Hoboken). 2025;8(3):e70188.","journal-title":"Cancer Rep (Hoboken)"},{"issue":"10","key":"4010_CR59","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.7150\/ijbs.85285","volume":"19","author":"M Ye","year":"2023","unstructured":"Ye M, Hu C, Chen T, et al. FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression. Int J Biol Sci. 2023;19(10):3115\u201327.","journal-title":"Int J Biol Sci"},{"issue":"15","key":"4010_CR60","doi-asserted-by":"publisher","first-page":"6561","DOI":"10.7150\/thno.44868","volume":"10","author":"C Zhang","year":"2020","unstructured":"Zhang C, Liao Y, Liu P, et al. FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism. Theranostics. 2020;10(15):6561\u201380.","journal-title":"Theranostics"},{"key":"4010_CR61","doi-asserted-by":"publisher","unstructured":"O\u2019Sullivan SE, Kaczocha M. FABP5 as a novel molecular target in prostate cancer. Drug Discov Today. 2020; 25(11):2056-61. https:\/\/doi.org\/10.1016\/j.drudis.2020.09.018","DOI":"10.1016\/j.drudis.2020.09.018"},{"issue":"1","key":"4010_CR62","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s42003-020-01367-5","volume":"3","author":"J Seo","year":"2020","unstructured":"Seo J, Jeong DW, Park JW, et al. Fatty-acid-induced FABP5\/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells. Commun Biol. 2020;3(1):638.","journal-title":"Commun Biol"},{"issue":"1","key":"4010_CR63","doi-asserted-by":"publisher","first-page":"2085432","DOI":"10.1080\/2162402X.2022.2085432","volume":"11","author":"Z Liu","year":"2022","unstructured":"Liu Z, Gao Z, Li B, et al. Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression. Oncoimmunology. 2022;11(1):2085432.","journal-title":"Oncoimmunology"},{"issue":"8","key":"4010_CR64","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41419-023-05987-7","volume":"14","author":"R Xu","year":"2023","unstructured":"Xu R, Song J, Ruze R, et al. SQLE promotes pancreatic cancer growth by attenuating ER stress and activating lipid rafts-regulated Src\/PI3K\/Akt signaling pathway. Cell Death Dis. 2023;14(8):497.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4010_CR65","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12935-023-02997-5","volume":"23","author":"F Zou","year":"2023","unstructured":"Zou F, Chen W, Song T, et al. SQLE knockdown inhibits bladder cancer progression by regulating the PTEN\/AKT\/GSK3\u03b2 signaling pathway through P53. Cancer Cell Int. 2023;23(1):221.","journal-title":"Cancer Cell Int"},{"key":"4010_CR66","doi-asserted-by":"publisher","first-page":"101993","DOI":"10.1016\/j.mcp.2024.101993","volume":"78","author":"Q Song","year":"2024","unstructured":"Song Q, He L, Feng J. SQLE promotes osteosarcoma progression via activating TGF\u03b2\/SMAD signaling pathway. Mol Cell Probes. 2024;78:101993.","journal-title":"Mol Cell Probes"},{"key":"4010_CR67","doi-asserted-by":"publisher","first-page":"skae249","DOI":"10.1093\/jas\/skae249","volume":"102","author":"L Chen","year":"2024","unstructured":"Chen L, Qi Y, Shi M, et al. A mixed animal and plant protein source replacing fishmeal affects bile acid metabolism and apoptosis in largemouth bass (Micropterus salmoides). J Anim Sci. 2024;102:skae249.","journal-title":"J Anim Sci"},{"issue":"1","key":"4010_CR68","doi-asserted-by":"publisher","first-page":"14629","DOI":"10.1038\/s41598-023-41343-7","volume":"13","author":"H Mao","year":"2023","unstructured":"Mao H, Wang R, Shao F, et al. HMGCS2 serves as a potential biomarker for Inhibition of renal clear cell carcinoma growth. Sci Rep. 2023;13(1):14629.","journal-title":"Sci Rep"},{"issue":"8","key":"4010_CR69","doi-asserted-by":"publisher","first-page":"152464","DOI":"10.1016\/j.prp.2019.152464","volume":"215","author":"S Wan","year":"2019","unstructured":"Wan S, Xi M, Zhao HB, et al. HMGCS2 functions as a tumor suppressor and has a prognostic impact in prostate cancer. Pathol Res Pract. 2019;215(8):152464.","journal-title":"Pathol Res Pract"},{"issue":"22","key":"4010_CR70","doi-asserted-by":"publisher","first-page":"8015","DOI":"10.3390\/molecules27228015","volume":"27","author":"FM Suk","year":"2022","unstructured":"Suk FM, Wu CY, Chiu WC, et al. HMGCS2 mediation of ketone levels affects Sorafenib treatment efficacy in liver cancer cells. Molecules. 2022;27(22):8015.","journal-title":"Molecules"},{"issue":"1","key":"4010_CR71","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1186\/s12885-024-12675-y","volume":"24","author":"L Li","year":"2024","unstructured":"Li L, Huang YT, Wang LT, et al. ADH4-a potential prognostic marker for hepatocellular carcinoma with possible immune-related implications. BMC Cancer. 2024;24(1):927.","journal-title":"BMC Cancer"},{"issue":"12","key":"4010_CR72","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.3390\/genes13122254","volume":"13","author":"SH Karunakara","year":"2022","unstructured":"Karunakara SH, Puttahanumantharayappa LD, Sannappa Gowda NG, et al. Novel insights into MEG3\/miR664a-3p\/ADH4 axis and its possible role in hepatocellular carcinoma from an in Silico perspective. Genes (Basel). 2022;13(12):2254.","journal-title":"Genes (Basel)"},{"issue":"4","key":"4010_CR73","doi-asserted-by":"publisher","first-page":"e13576","DOI":"10.1111\/cpr.13576","volume":"57","author":"Y Liang","year":"2024","unstructured":"Liang Y, Zhang R, Biswas S, et al. Integrated single-cell transcriptomics reveals the hypoxia-induced inflammation-cancer transformation in NASH-derived hepatocellular carcinoma. Cell Prolif. 2024;57(4):e13576.","journal-title":"Cell Prolif"},{"key":"4010_CR74","doi-asserted-by":"publisher","first-page":"1276654","DOI":"10.3389\/fonc.2023.1276654","volume":"13","author":"X He","year":"2023","unstructured":"He X, Lan H, Jin K, et al. Cholesterol in colorectal cancer: an essential but tumorigenic precursor? Front Oncol. 2023;13:1276654.","journal-title":"Front Oncol"},{"issue":"10","key":"4010_CR75","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1194\/jlr.M069807","volume":"57","author":"H Liu","year":"2016","unstructured":"Liu H, Pathak P, Boehme S, et al. Cholesterol 7\u03b1-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis. J Lipid Res. 2016;57(10):1831\u201344.","journal-title":"J Lipid Res"},{"issue":"1","key":"4010_CR76","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12905-024-03061-8","volume":"24","author":"HH Shi","year":"2024","unstructured":"Shi HH, Mugaanyi J, Lu C, et al. A paradigm shift in cancer research based on integrative multi-omics approaches: glutaminase serves as a pioneering cuproptosis-related gene in pan-cancer. BMC Womens Health. 2024;24(1):213.","journal-title":"BMC Womens Health"},{"issue":"1","key":"4010_CR77","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13046-025-03286-x","volume":"44","author":"B Tian","year":"2025","unstructured":"Tian B, Wang Z, Cao M, et al. CCR8 antagonist suppresses liver cancer progression via turning tumor-infiltrating Tregs into less immunosuppressive phenotype. J Exp Clin Cancer Res. 2025;44(1):113.","journal-title":"J Exp Clin Cancer Res"},{"key":"4010_CR78","doi-asserted-by":"crossref","unstructured":"Ikeda Y, Funamoto M, Itami H et al. Deletion of H-ferritin in macrophages mitigates the development of steatohepatitis and hepatocellular carcinoma in mice. Am J Physiol Gastrointest Liver Physiol. 2025 ;328(5): G533-G544.","DOI":"10.1152\/ajpgi.00328.2024"},{"key":"4010_CR79","doi-asserted-by":"publisher","first-page":"119163","DOI":"10.1016\/j.atherosclerosis.2025.119163","volume":"403","author":"SAEV Wouw","year":"2025","unstructured":"Wouw SAEV, Loix M, Ottenhoff R, et al. Global deletion of the LXR-regulated gene EEPD1 reveals macrophage-specific changes in lipid metabolism and cholesterol efflux. Atherosclerosis. 2025;403:119163.","journal-title":"Atherosclerosis"},{"key":"4010_CR80","doi-asserted-by":"publisher","first-page":"122818","DOI":"10.1016\/j.lfs.2024.122818","volume":"351","author":"B Nair","year":"2024","unstructured":"Nair B, Kamath AJ, Tergaonkar V, et al. Mast cells and the gut-liver axis: implications for liver disease progression and therapy. Life Sci. 2024;351:122818.","journal-title":"Life Sci"},{"issue":"1","key":"4010_CR81","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12885-024-11904-8","volume":"24","author":"E Ali","year":"2024","unstructured":"Ali E, \u010cervenkov\u00e1 L, P\u00e1lek R, et al. Prognostic role of macrophages and mast cells in the microenvironment of hepatocellular carcinoma after resection. BMC Cancer. 2024;24(1):142.","journal-title":"BMC Cancer"},{"issue":"11","key":"4010_CR82","doi-asserted-by":"publisher","first-page":"e1031","DOI":"10.1093\/oncolo\/oyad113","volume":"28","author":"X Wei","year":"2023","unstructured":"Wei X, Michelakos T, He Q, et al. Association of tumor cell metabolic subtype and immune response with the clinical course of hepatocellular carcinoma. Oncologist. 2023;28(11):e1031\u201342.","journal-title":"Oncologist"},{"issue":"12","key":"4010_CR83","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.4158\/EP-2020-0347","volume":"26","author":"DS Schade","year":"2020","unstructured":"Schade DS, Shey L, Eaton RP. Cholesterol review: A metabolically important molecule. Endocr Pract. 2020;26(12):1514\u201323.","journal-title":"Endocr Pract"},{"key":"4010_CR84","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-physiol-060821-014008","volume":"84","author":"L Simon","year":"2022","unstructured":"Simon L, Souza-Smith FM, Molina PE. Alcohol-Associated tissue injury: current views on pathophysiological mechanisms. Annu Rev Physiol. 2022;84:87\u2013112.","journal-title":"Annu Rev Physiol"},{"issue":"17","key":"4010_CR85","doi-asserted-by":"publisher","first-page":"10037","DOI":"10.3390\/ijms231710037","volume":"23","author":"A Fukushi","year":"2022","unstructured":"Fukushi A, Kim HD, Chang YC, et al. Revisited metabolic control and reprogramming cancers by means of the Warburg effect in tumor cells. Int J Mol Sci. 2022;23(17):10037.","journal-title":"Int J Mol Sci"},{"issue":"20","key":"4010_CR86","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.3390\/ijms20205055","volume":"20","author":"HS Cheng","year":"2019","unstructured":"Cheng HS, Tan WR, Low ZS, et al. Exploration and development of PPAR modulators in health and disease: an update of clinical evidence. Int J Mol Sci. 2019;20(20):5055.","journal-title":"Int J Mol Sci"},{"issue":"20","key":"4010_CR87","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.3390\/cells11203215","volume":"11","author":"S Ballav","year":"2022","unstructured":"Ballav S, Biswas B, Sahu VK, et al. PPAR-\u03b3 partial agonists in Disease-Fate decision with special reference to cancer. Cells. 2022;11(20):3215.","journal-title":"Cells"},{"issue":"5","key":"4010_CR88","first-page":"e2078","volume":"7","author":"S Tripathi","year":"2024","unstructured":"Tripathi S, Gupta E, Galande S. Statins as anti-tumor agents: A paradigm for repurposed drugs. Cancer Rep (Hoboken). 2024;7(5):e2078.","journal-title":"Cancer Rep (Hoboken)"},{"key":"4010_CR89","doi-asserted-by":"publisher","first-page":"1109019","DOI":"10.3389\/fneur.2022.1109019","volume":"13","author":"D Zhu","year":"2023","unstructured":"Zhu D, Zhu Y, Liu L, et al. Metabolomic analysis of vascular cognitive impairment due to hepatocellular carcinoma. Front Neurol. 2023;13:1109019.","journal-title":"Front Neurol"},{"issue":"23","key":"4010_CR90","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.3390\/cells11233924","volume":"11","author":"J Chen","year":"2022","unstructured":"Chen J, Wang R, Liu Z, et al. Unbalanced glutamine partitioning between CD8T cells and cancer cells accompanied by immune cell dysfunction in hepatocellular carcinoma. Cells. 2022;11(23):3924.","journal-title":"Cells"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04010-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-04010-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04010-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:05:38Z","timestamp":1764075938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-04010-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4010"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-04010-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"type":"electronic","value":"2730-6011"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2162"}}